Doreen Schreiber1, Thomas Rostock2, Max Fröhlich2, Arian Sultan2, Helge Servatius2, Boris A Hoffmann2, Jakob Lüker2, Imke Berner2, Benjamin Schäffer2, Karl Wegscheider2, Susanne Lezius2, Stephan Willems2, Daniel Steven2. 1. From the Department of Electrophysiology, University Heart Center (D.S., M.F., A.S., H.S., B.A.H., J.L., B.S., S.W., D.S.) and Department of Medical Biometry and Epidemiology (K.W., S.L.), University Hospital Eppendorf, Hamburg, Germany; II Medical Clinic, Department of Electrophysiology, Johannes-Gutenberg University, Mainz (T.R.); and Center for Electrophysiology at Klinikum Links der Weser, Bremen, Germany (I.B.). d.schreiber@uke.de. 2. From the Department of Electrophysiology, University Heart Center (D.S., M.F., A.S., H.S., B.A.H., J.L., B.S., S.W., D.S.) and Department of Medical Biometry and Epidemiology (K.W., S.L.), University Hospital Eppendorf, Hamburg, Germany; II Medical Clinic, Department of Electrophysiology, Johannes-Gutenberg University, Mainz (T.R.); and Center for Electrophysiology at Klinikum Links der Weser, Bremen, Germany (I.B.).
Abstract
BACKGROUND: In the meantime, catheter ablation is widely used for the treatment of persistent atrial fibrillation (AF). There is a paucity of data about long-term outcomes. This study evaluates (1) 5-year single and multiple procedure success and (2) prognostic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise approach aiming at AF termination. METHODS AND RESULTS: A total of 549 patients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007-2009). A total of 493 patients were included (Holter ECGs ≥ every 6 months). Mean follow-up was 59 ± 16 months with 2.1 ± 1.1 procedures per patient. Single and multiple procedure success rates were 20.1% and 55.9%, respectively (80% off antiarrhythmic drug). Antiarrhythmic drug-free multiple procedure success was 46%. Long-term recurrences (n=171) were paroxysmal AF in 48 patients (28%) and persistent AF/atrial tachycardia in 123 patients (72%). Multivariable recurrent event analysis revealed the following factors favoring arrhythmia recurrence: failure to terminate AF during index procedure (hazard ratio [HR], 1.279; 95% confidence interval [CI], 1.093-1.497; P = 0.002), number of procedures (HR, 1.154; 95% CI, 1.051-1.267; P = 0.003), female sex (HR, 1.263; 95% CI, 1.027-1.553; P = 0.027), and the presence of structural heart disease (HR, 1.236; 95% CI, 1.003-1.524; P = 0.047). AF termination was correlated with a higher rate of consecutive procedures because of atrial tachycardia recurrences (P = 0.003; HR, 1.71; 95% CI, 1.20-2.43). CONCLUSIONS: Catheter ablation of persistent AF using the stepwise approach provides limited long-term freedom of arrhythmias often requiring multiple procedures. AF termination, the number of procedures, sex, and the presence of structural heart disease correlate with outcome success. AF termination is associated with consecutive atrial tachycardia procedures.
BACKGROUND: In the meantime, catheter ablation is widely used for the treatment of persistent atrial fibrillation (AF). There is a paucity of data about long-term outcomes. This study evaluates (1) 5-year single and multiple procedure success and (2) prognostic factors for arrhythmia recurrences after catheter ablation of persistent AF using the stepwise approach aiming at AF termination. METHODS AND RESULTS: A total of 549 patients with persistent AF underwent de novo catheter ablation using the stepwise approach (2007-2009). A total of 493 patients were included (Holter ECGs ≥ every 6 months). Mean follow-up was 59 ± 16 months with 2.1 ± 1.1 procedures per patient. Single and multiple procedure success rates were 20.1% and 55.9%, respectively (80% off antiarrhythmic drug). Antiarrhythmic drug-free multiple procedure success was 46%. Long-term recurrences (n=171) were paroxysmal AF in 48 patients (28%) and persistent AF/atrial tachycardia in 123 patients (72%). Multivariable recurrent event analysis revealed the following factors favoring arrhythmia recurrence: failure to terminate AF during index procedure (hazard ratio [HR], 1.279; 95% confidence interval [CI], 1.093-1.497; P = 0.002), number of procedures (HR, 1.154; 95% CI, 1.051-1.267; P = 0.003), female sex (HR, 1.263; 95% CI, 1.027-1.553; P = 0.027), and the presence of structural heart disease (HR, 1.236; 95% CI, 1.003-1.524; P = 0.047). AF termination was correlated with a higher rate of consecutive procedures because of atrial tachycardia recurrences (P = 0.003; HR, 1.71; 95% CI, 1.20-2.43). CONCLUSIONS: Catheter ablation of persistent AF using the stepwise approach provides limited long-term freedom of arrhythmias often requiring multiple procedures. AF termination, the number of procedures, sex, and the presence of structural heart disease correlate with outcome success. AF termination is associated with consecutive atrial tachycardia procedures.
Authors: Melanie Gunawardene; S Willems; B Schäffer; J Moser; R Ö Akbulak; M Jularic; C Eickholt; J Nührich; C Meyer; P Kuklik; S Sehner; V Czerner; B A Hoffmann Journal: Clin Res Cardiol Date: 2016-07-19 Impact factor: 5.460
Authors: Matthew C Henn; Timothy S Lancaster; Jacob R Miller; Laurie A Sinn; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano Journal: J Thorac Cardiovasc Surg Date: 2015-08-08 Impact factor: 5.209
Authors: Gustavo R Goldenberg; Masa Ono; Arash Aryana; Andre d'Avila; Eduardo B Saad; Steve K Singh; Sheldon M Singh Journal: J Interv Card Electrophysiol Date: 2016-10-20 Impact factor: 1.900
Authors: Jakob Lüker; Arian Sultan; Susanne Sehner; Boris Hoffmann; Helge Servatius; Stephan Willems; Daniel Steven Journal: Heart Vessels Date: 2015-11-06 Impact factor: 2.037
Authors: Barbara Bellmann; Tina Lin; Peter Ruppersberg; Marit Zettwitz; Selma Guttmann; Verena Tscholl; Patrick Nagel; Mattias Roser; Ulf Landmesser; Andreas Rillig Journal: Clin Res Cardiol Date: 2018-05-09 Impact factor: 5.460